Drawing for ANGLE

USPTO serial 79204258

ANGLE

Reviewed by CopyMark Law Group

Reg. 5505329Status 707Registered
Filing date
Status date
Registration date
Jul 3, 2018
Examiner
TWOHIG, SHANNON MARIE
Law office
TMO LAW OFFICE 121

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with ANGLE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210United States

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations and reagents for scientific or research use; chemical reagents for non-medical purposes; reagents for in vitro use; chemical preparations in the nature of [ buffer solutions and ] reagents for scientific and research use for use with laboratory apparatus, namely, separation apparatus [ and analysis apparatus ] ; [ biomarkers, namely, molecular biomarkers for scientific or research use; ] chemical test kits and diagnostic kits comprised of diagnostic reagents and assay components for scientific, research, clinical and medical laboratory useACTIVE—
005[ Diagnostic reagents and assay components for clinical, medical and medical laboratory use; diagnostic kits comprised of diagnostic reagents and assay components for clinical, medical and medical laboratory use; not including any such goods that are prescription only pharmaceuticals, but including such non-pharmaceutical goods that are for companion diagnostics ]SECTION 71 - CANCELLED—
009Apparatus, equipment and instruments for scientific, laboratory, diagnostic or general research use, namely, laboratory analyzers, pre-packed columns for use in separation and purification, glassware, tubes, namely, sample tubes, reagent tubes, [ phlebotomy tubes and plastic tubes ] ; apparatus, equipment and instruments, namely, cassettes for harvesting cancer cells, for cytology, histology and for use in detecting cancerous conditions for laboratory or research use; apparatus in the nature of cassettes for harvesting rare cells for use in laboratory, diagnostic or general research use; cell analyser providing quantitative cell analysis for scientific, laboratory or general research use and disposable cassettes therefor for harvesting rare cells; apparatus for use in testing and analysing blood and blood cells for laboratory or research use; [ diagnostic reagent kits for the analysis of data and test results, all for laboratory use, and none for medical use; biological analysis computer software; ] parts and fitting for the aforesaid goods, namely medical laboratory research instruments for use in the detection of cancerACTIVE—
010Medical diagnostic apparatus, equipment and instruments for clinical diagnosis of cancer, namely, apparatus for medical diagnostic testing in the field of cancer; [ medical testing apparatus, equipment and instruments; ] medical testing kits consisting primarily of medical diagnostic apparatus for testing body fluids including blood and plasma, rare cells for use in detecting cancerous conditions; parts and fittings for the aforesaid goods, namely, diagnostic apparatus, equipment and instruments for cytology, histology and for use in detecting cancerACTIVE—
042Biological [ , scientific ] and medical research and consultation services related thereto; [ product research and development in the fields of biology and medical sciences; custom development of biochemical reagents; ] services of a chemical laboratory; medical research laboratory services, in particular in the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 16, 2026INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Mar 1, 2026INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Feb 28, 2026INPCINVALIDATION PROCESSED—
Nov 28, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 14, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 14, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 14, 202571.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Jan 13, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 2, 2024ES71TEAS SECTION 71 RECEIVED—
Jul 3, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 2, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 26, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 5, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 5, 2018FIMPFINAL DISPOSITION PROCESSED—
Oct 3, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 3, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 15, 2018ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 17, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 17, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 13, 2018GPNXNOTIFICATION PROCESSED BY IB—
Mar 28, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 28, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 28, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 10, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 27, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 27, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 27, 2018ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 6, 2017GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Nov 6, 2017GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 6, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 6, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 5, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 5, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 26, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 26, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 29, 2017RFNPREFUSAL PROCESSED BY IB—
Apr 7, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 7, 2017RFRRREFUSAL PROCESSED BY MPU—
Apr 7, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 7, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 6, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2017DOCKASSIGNED TO EXAMINER—
Apr 3, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 30, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance